contact ussite map
Juvaris plans to start up four (4) clinical studies in 2008.
Juvaris In the News
Juvaris is Conducting Clinical Trials.
Juvaris Technology
Juvaris BioTherapeutics Announces License to Colby Pharmaceutical Company for JVRS-100 and CLDC (Cationic Lipid-DNA Complex) Platform for Human Health
Juvaris BioTherapeutics Announces Publication of Preclinical Anti-Leukemic Effects of JVRS-100 Immunotherapy
Juvaris BioTherapeutics Completes Second Close on $25 million Series B Financing
More »